Ignite Creation Date:
2025-12-25 @ 12:18 AM
Ignite Modification Date:
2026-01-06 @ 6:06 PM
Study NCT ID:
NCT03235258
Status:
COMPLETED
Last Update Posted:
2021-04-13
First Post:
2016-09-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cohort of HIV-infected Children
Sponsor:
ANRS, Emerging Infectious Diseases
Organization:
Study Overview
Official Title:
ANRS CO10 EPF - Cohort of HIV-infected Children
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EPF
Brief Summary:
The purpose of this study is to describe the conditions of access to early treatment of children infected with HIV, their management on the long-term, and impact on growth, clinical and immunovirological prognosis, adherence to treatment, living conditions
Detailed Description:
The CO10 EPF paediatric cohort includes therapeutic, clinical and biological detailed questionnaires. The data are collected by the doctors every three months to 2 years and then every 6 months until to 18 years or every year by a simplified questionnaire if medical follow up continues outside of a participating site.
After 18 years of age, the patients are eligibile for the ANRS CO19-Coverte cohort.
After 18 years of age, the patients are eligibile for the ANRS CO19-Coverte cohort.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: